NURO News and Press, NeuroMetrix Inc. From 01/18/22

NeuroMetrix Inc. ( NASDAQ: NURO ) shot up 35% after announcing that the FDA awarded it Breakthrough Device Designation for its Quell technology . This innovative technology is designed to help reduce severe to moderate chemo symptoms that persist for at least six months afte...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Blink Charging (NASDAQ: BLNK ) stock is getting a boost on Tuesday from a deal with General Motors (NYSE: GM ) for its electric vehicle (EV) chargers. Source: David Tonelson/Shutterstock.com Let’s...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips NeuroMetrix (NASDAQ: NURO ) stock is rocketing higher on Tuesday thanks to the U.S. Food and Drug Administration (FDA) granting it Breakthrough Designation for one of its devices. Source: JHVEPhoto / Shutterstock....

If you’re looking for penny stocks to buy, there are a few “secret” ways to build your watch list. Over the weekend, we posted an article: 10 Secret Ways To Find The Best Penny Stocks To Buy In 2022 , and the first way to do so was by looking for news. This has beco...

WOBURN, Mass., Jan. 18, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that its Quell ® technology has received Breakthrough Designation from the U.S. Food and Drug Administration (FDA) for reducing moderate to severe symptoms of chemotherapy induced peri...

Whether or not you’re trading penny stocks or higher-priced stocks, you need a broker to place your orders. Thanks to millions of new market participants joining the ranks over the last few years, mobile-first platforms have grown popular. What’s more, many of these offer ...

WOBURN, Mass., Jan. 10, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has appointed Brandi Damkier as Vice President, Clinical Partnerships. Ms. Damkier will be responsible for expanding the Company's DPNCheck ® clinical partnerships and advancin...

WOBURN, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will be presenting at the H.C. Wainwright BioConnect Conference to be held virtually on January 10-13, 2022. Dr...

NeuroMetrix, Inc. (NURO) Q3 2021 Earnings Conference Call October 21, 2021 08:00 AM ET Company Participants Thomas Higgins - Senior Vice President & Chief Financial Officer Dr. Shai Gozani - President & Chief Executive Officer Presentation Operator Good morning and welcome to the Neur...

WOBURN, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended September 30, 2021. The Company is a leader in proprietary non-invasive medical devices for the diagnosis and treatment of pain and neurol...